BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 28246146)

  • 1. Psychometric validation of the Coronary Revascularisation Outcome Questionnaire (CROQv2) in the context of the NHS Coronary Revascularisation PROMs Pilot.
    Schroter S; Miles R; Green S; Jackson M
    BMJ Open; 2017 Feb; 7(2):e015915. PubMed ID: 28246146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translation and validation of the Norwegian version of the Coronary Revascularisation Outcome Questionnaire.
    Lillevik SA; Schroter S; Hanssen TA
    Eur J Cardiovasc Nurs; 2018 Jan; 17(1):36-44. PubMed ID: 28617044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary revascularisation outcome questionnaire (CROQ): development and validation of a new, patient based measure of outcome in coronary bypass surgery and angioplasty.
    Schroter S; Lamping DL
    Heart; 2004 Dec; 90(12):1460-6. PubMed ID: 15547029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric evaluation of the Coronary Revascularisation Outcome Questionnaire (CROQ) in Norwegian patients admitted to elective coronary angiography and possible percutaneous coronary intervention.
    Myrbakk IN; Friborg O; Høye A; Steigen T; Bergvik S
    Health Qual Life Outcomes; 2022 Feb; 20(1):21. PubMed ID: 35123504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary revascularisation outcome questionnaire: validation study of the Serbian version.
    Aleksic N; Putnik S; Schroter S; Pavlovic V; Bumbasirevic U; Zlatkovic M; Bilbija I; Matkovic M; Jovanovic A; Pekmezovic T; Maric G
    Qual Life Res; 2022 Jun; 31(6):1883-1895. PubMed ID: 35034321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability and validity of the Korean version of the coronary revascularization outcome questionnaire.
    Kim M; Seo J; Hwang JY; Park KS
    Health Qual Life Outcomes; 2017 Feb; 15(1):37. PubMed ID: 28202043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a social inclusion index to capture subjective and objective life domains (Phase II): psychometric development study.
    Huxley P; Evans S; Madge S; Webber M; Burchardt T; McDaid D; Knapp M
    Health Technol Assess; 2012; 16(1):iii-vii, ix-xii, -1-241. PubMed ID: 22260923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translation, adaptation and validation of the Coronary Revascularization Outcome Questionnaire into Greek.
    Takousi MG; Schmeer S; Manaras I; Olympios CD; Fakiolas CN; Makos G; Troop NA
    Eur J Cardiovasc Nurs; 2016 Apr; 15(2):134-41. PubMed ID: 26082475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Malay version of SF-36 health survey instrument: testing data quality, scaling assumptions, reliability and validity in post-coronary artery bypass grafting (CABG) surgery patients at the National Heart Institute (Institut Jantung Negara-IJN), Kuala Lumpur.
    Musa AF; Yasin MSM; Smith J; Yakub MA; Nordin RB
    Health Qual Life Outcomes; 2021 Feb; 19(1):50. PubMed ID: 33563262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translation and validation study of the Japanese versions of the Coronary Revascularisation Outcome Questionnaire (CROQ-J).
    Seki S; Kato N; Ito N; Kinugawa K; Ono M; Motomura N; Yao A; Watanabe M; Imai Y; Takeda N; Inoue M; Hatano M; Kazuma K
    Eur J Cardiovasc Nurs; 2011 Mar; 10(1):22-30. PubMed ID: 20460193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DEVELOPMENT AND VALIDATION OF 'SURE': A PATIENT REPORTED OUTCOME MEASURE (PROM) FOR RECOVERY FROM DRUG AND ALCOHOL DEPENDENCE.
    Neale J; Vitoratou S; Finch E; Lennon P; Mitcheson L; Panebianco D; Rose D; Strang J; Wykes T; Marsden J
    Drug Alcohol Depend; 2016 Aug; 165():159-67. PubMed ID: 27344196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness of the coronary revascularisation outcome questionnaire compared with the SF-36 and Seattle Angina Questionnaire.
    Schroter S; Lamping DL
    Qual Life Res; 2006 Aug; 15(6):1069-78. PubMed ID: 16900287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of an audit instrument: the Prostate Outcomes Questionnaire.
    Lamping DL; Rowe P; Black N; Lessof L
    Br J Urol; 1998 Jul; 82(1):49-62. PubMed ID: 9698662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tests of data quality, scaling assumptions, reliability, and construct validity of the SF-36 health survey in people who abuse heroin.
    Chiu EC; Hsueh IP; Hsieh CH; Hsieh CL
    J Formos Med Assoc; 2014 Apr; 113(4):234-41. PubMed ID: 24685299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canadian-French, German and UK versions of the Child Health Questionnaire: methodology and preliminary item scaling results.
    Landgraf JM; Maunsell E; Speechley KN; Bullinger M; Campbell S; Abetz L; Ware JE
    Qual Life Res; 1998 Jul; 7(5):433-45. PubMed ID: 9691723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome.
    Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
    Health Technol Assess; 2004 Mar; 8(9):iii, 1-48. PubMed ID: 14982653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiff cardiac ablation patient-reported outcome measure (C-CAP): validation of a new questionnaire set for patients undergoing catheter ablation for cardiac arrhythmias in the UK.
    White J; Withers KL; Lencioni M; Carolan-Rees G; Wilkes AR; Wood KA; Patrick H; Cunningham D; Griffith M
    Qual Life Res; 2016 Jun; 25(6):1571-83. PubMed ID: 26659900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation and psychometric properties of the Norwegian version of the heart continuity of care questionnaire (HCCQ).
    Valaker I; Fridlund B; Wentzel-Larsen T; Hadjistavropoulos H; Nordrehaug JE; Rotevatn S; Råholm MB; Norekvål TM;
    BMC Med Res Methodol; 2019 Mar; 19(1):62. PubMed ID: 30885143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trials.
    Elstein D; Belmatoug N; Deegan P; Göker-Alpan Ö; Hughes DA; Schwartz IVD; Weinreb N; Bonner N; Panter C; Fountain D; Lenny A; Longworth L; Miller R; Shah K; Schenk J; Sen R; Zimran A
    Orphanet J Rare Dis; 2022 Jan; 17(1):9. PubMed ID: 34991656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do patients have a say? A narrative review of the development of patient-reported outcome measures used in elective procedures for coronary revascularisation.
    Peeters G; Barker AL; Talevski J; Ackerman I; Ayton DR; Reid C; Evans SM; Stoelwinder JU; McNeil JJ
    Qual Life Res; 2018 May; 27(5):1369-1380. PubMed ID: 29380228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.